Prostamax (Lys-Glu-Asp-Pro) (Простамакс)

Standard manufacturer protocol: 20 clicks (2 mg) daily in 1 dose (1 click = 100 mcg). Set pen programmer to "20" (1 division = 1 click). Subcutaneous injection into abdomen or front of thigh. After injection, wait 10 seconds before withdrawing needle. Alternate injection sites to avoid lumps.

1 pen 20 mg (200 clicks) — is a full 10-day course. Recommended 2–3 courses per year with 4–6 month breaks between courses for bioregulatory effect.

Storage: 2–8°C in refrigerator. MSSPT technology makes the formula tolerant to short-term temperature deviations above 8°C during delivery.

Before starting — consultation with DOZA specialist, especially if you have existing urological conditions or are taking other medications.

Prostamax (Lys-Glu-Asp-Pro) is a bioregulatory tetrapeptide composed of four amino acids: lysine-glutamic acid-aspartic acid-proline. Developed based on peptide bioregulator research from the St. Petersburg Institute of Bioregulation and Gerontology. The sequence is a fragment of the natural peptide complex of the prostate gland and works on the principle of "short peptides": penetrates prostate cells, regulates specific gene expression and normalizes tissue function.

In studies, Prostamax has shown potential in supporting prostate function in benign hyperplasia, chronic prostatitis, reducing gland tissue swelling and inflammation, normalizing urination frequency (especially nocturnal), improving microcirculation, supporting hormonal balance and men's health. Safety profile is excellent: according to the manufacturer, no negative side effects have been recorded.

DOZA supplies Prostamax in pre-mixed pen format manufactured by Pen Peptide: 20 mg (200 clicks, 1 click = 100 mcg) in stabilized MSSPT (Molecular Structure Stabilization Process Technology) form. Purity ≥98%, synthesis in certified GMP laboratories, storage 2–8°C with cold chain to your door. 1 pen = 1 full course (10 days). Recommended 2–3 courses per year for bioregulatory effect.

Prostamax acts through the epigenetic mechanism of short peptides (Khavinson school, St. Petersburg Institute of Bioregulation and Gerontology). The tetrapeptide Lys-Glu-Asp-Pro penetrates prostate cells, binds to regulatory DNA regions and normalizes expression of specific genes responsible for protein synthesis and gland function (Khavinson et al., Bull Exp Biol Med, 2003). Reduces levels of pro-inflammatory cytokines (IL-6, TNF-α) in prostate tissues, restores balance between cell proliferation and apoptosis, improves microcirculation and reduces swelling (Anisimov et al., Biogerontology, 2006). Does not affect systemic hormone levels — acts exclusively locally at the tissue level. Short peptides (2-4 amino acids) penetrate membranes without receptor-mediated transport — a unique mechanism among therapeutic molecules.